Brain, Vol. 125, No. 1, 166-175,
January 1, 2002
© 2002 Oxford University Press
Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies
A clinical and electrophysiological study of 20 patients
1Department of Neurology, Hôpital Bellevue, Saint-Etienne, 2Department of Neurology, Hôpital Pierre Wertheimer, 3Department of Electromyography, Hôpital Pierre Wertheimer, and 4Department of Electromyography, Hôpital de la Croix Rousse, Lyon, France Correspondence to: Jean-Christophe Antoine, Service de Neurologie, Hôpital Bellevue, Boulevard Pasteur, 42055 Saint-Etienne Cedex 02, France E-mail: 113464.3717{at}compuserve.com
Although paraneoplastic subacute sensory neuronopathy is the most frequent presentation of peripheral neuropathy in patients with anti-Hu antibodies, other neuropathies have been reported. In order to investigate the clinical and electrophysiological manifestations of neuropathies associated with anti-Hu antibodies, we conducted a retrospective study of 20 patients. For the electrophysiological study, each nerve was classified as normal, demyelinating, axonal/neuronal or axonal/demyelinating. Peripheral neuropathy was the presenting symptom in 95% of patients. CNS and autonomic neuropathy were present in 40% and 30% of patients, respectively. The course of the neuropathy was acute, mimicking Guillain–Barré syndrome in one patient (5%), and subacute (55%) or progressive (40%) in the others. Clinically, the neuropathy was sensory (70%), sensorimotor (25%) or motor (5%). At onset, symptoms were symmetrical (65%), asymmetrical (25%) or multifocal (10%). Pain was a predominant manifestation (80%). Amyotrophia and fasciculations were rare. The median Rankin’s score was 2, three patients having an indolent form. Electrophysiology showed the axonal/neuronal pattern to be the most frequent (46.9% of studied nerves); an axonal/demyelinating or demyelinating pattern being seen in 18.3% and 4.9% of nerves, respectively. The axonal/neuronal pattern was more frequent in sensory nerves and the mixed axonal/demyelinating pattern more frequent in motor nerves (P < 0.01). A higher proportion of abnormal nerves correlated with a progressive course (P < 0.05) or a Rankin’s score between 3 and 5 (P < 0.01). In patients with sensory neuropathy, 88.5% of sensory nerves were abnormal, mostly with an axonal/neuronal pattern. In addition, 47% of motor nerves were abnormal so that only four out of 14 patients with a clinically pure sensory neuropathy (28.6%) had an electrophysiological pattern typical of sensory neuronopathy. In patients with a sensorimotor neuropathy, 96.6% of sensory and 71% of motor nerves were abnormal. The only statistical difference between sensory and sensorimotor neuropathies was that patients with sensorimotor neuropathy had more frequent motor nerve involvement (P < 0.05) without differences concerning the distribution of the abnormal patterns. Needle neuromyography showed only limited evidence of motor neurone degeneration in both sensory and sensorimotor neuropathy. The present work shows that the typical clinical and electrophysiological pattern of subacute sensory neuronopathy is rarely encountered in patients with anti-Hu antibody and that motor nerve involvement is frequently seen, even in the absence of a motor deficit. In addition to their potential pathophysiological involvement in the mechanism of the paraneoplastic neuropathy, these findings have practical consequences for the diagnosis of the disorder.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-P. Camdessanche, G. Jousserand, K. Ferraud, C. Vial, P. Petiot, J. Honnorat, and J.-C. Antoine The pattern and diagnostic criteria of sensory neuronopathy: a case-control study Brain, July 1, 2009; 132(7): 1723 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Honnorat, S Cartalat-Carel, D Ricard, J P. Camdessanche, A F Carpentier, V Rogemond, F Chapuis, M Aguera, E Decullier, A M Duchemin, et al. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies J. Neurol. Neurosurg. Psychiatry, April 1, 2009; 80(4): 412 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Oki, H. Koike, M. Iijima, K. Mori, N. Hattori, M. Katsuno, T. Nakamura, M. Hirayama, F. Tanaka, M. Shiraishi, et al. Ataxic vs painful form of paraneoplastic neuropathy Neurology, August 7, 2007; 69(6): 564 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Goransson, A. Herigstad, A. B. Tjensvoll, E. Harboe, S. I. Mellgren, and R. Omdal Peripheral Neuropathy in Primary Sjogren Syndrome: A Population-Based Study Arch Neurol, November 1, 2006; 63(11): 1612 - 1615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Vinik, D. Anandacoomaraswamy, and J. Ullal Antibodies to Neuronal Structures: Innocent bystanders or neurotoxins? Diabetes Care, August 1, 2005; 28(8): 2067 - 2072. [Full Text] [PDF]
|
|
|
|
|
|
F Graus, J Y Delattre, J C Antoine, J Dalmau, B Giometto, W Grisold, J Honnorat, P S. Smitt, C. Vedeler, J J G M Verschuuren, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1135 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J Willison and J. B Winer CLINICAL EVALUATION AND INVESTIGATION OF NEUROPATHY J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(90002): ii3 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Konishi, K. Lindholm, L.-B. Yang, R. Li, and Y. Shen Isolation of Living Neurons from Human Elderly Brains Using the Immunomagnetic Sorting DNA-Linker System Am. J. Pathol., November 1, 2002; 161(5): 1567 - 1576. [Abstract] [Full Text] [PDF]
|
|